IBD's SMR Rating measures sales, margins and return on equity. Palantir held the best possible SMR Rating as it soared in the stock market on earnings.
Investor's Business Daily on MSN45m
Breakout Watch: Savvy Funds Love This Stock Eyeing 315% GrowthFlying high on huge demand, AppLovin stock resets to target a fresh breakout on forecasts of 315% earnings growth.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback